Evidence map›Paper›PMID 42562976›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Binding Interaction Analysis of Lysozyme and Brilliant Blue Using Surface Plasmon Resonance.

Zeynep Aleyna Kahraman, Şule Çoşkun, Simay Çungur, Ilgaz Taştekil, Emir Alper Türkoğlu

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zeynep Aleyna KahramanDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Health Sciences Turkey, İstanbul, Türkiye.
Şule ÇoşkunFaculty of Pharmacy, University of Health Sciences Turkey, İstanbul, Türkiye.
Simay ÇungurFaculty of Pharmacy, University of Health Sciences Turkey, İstanbul, Türkiye.
Ilgaz TaştekilDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Health Sciences Turkey, İstanbul, Türkiye.
Emir Alper TürkoğluGülhane Institute of Health Sciences, University of Health Sciences Turkey, Ankara, Türkiye. alper.turkoglu@sbu.edu.tr.ORCID http://orcid.org/0000-0001-7850-6456

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study presents a detailed in vitro experimental protocol for analyzing the molecular interaction between lysozyme and the synthetic dye Brilliant Blue FCF (BB). Lysozyme, a natural antimicrobial enzyme found in various secretions, plays a vital role in the innate immune system and oral health. BB, commonly used in food and cosmetic products, is known to interact with biological macromolecules. The binding interaction between these two molecules was investigated using a surface plasmon resonance (SPR) system employing Kretschmann's configuration. The gold SPR sensor surface was functionalized with 11-mercaptoundecanoic acid (MUA). The lysozyme from chicken egg white as a ligand was immobilized onto the functionalized sensor surface and varying concentrations of BB were injected through the SPR channels to evaluate binding kinetics. SPR data were analyzed through multistep software workflow including referencing, baseline correction, alignment, and kinetic fitting. The resulting sensorgrams enabled the determination of key parameters such as association (k

Indexed as

BenzenesulfonatesMuramidaseOxazinesSurface Plasmon ResonanceAnimalsChickensKineticsProtein BindingBenzenesulfonatesbrilliant blueMuramidaseOxazinesAffinity constantBrilliant blue FCFLysozymeSurface plasmon resonance

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.